Coming Together for Research & Collaboration
At the end of May, Open Medicine Foundation’s Founder and CEO, CRC Directors, and VP of Research Programs all attended the 2026 Invest in ME Research Conference in Cambridge, UK. This annual event brings together researchers, clinicians, and advocates committed to advancing ME/CFS and Long COVID research worldwide.
After the conference, the OMF team gathered for a three-day, in-person meeting. The discussion topics included:
- Standardization across all OMF projects,
- Results from our recent CTN Lite patient and caregiver survey, and
- Advanced scientific rationale for potential first treatment targets as part of CTN Lite.
These in-person gatherings help to facilitate collaborations and build momentum as we work to advance research on mechanisms, diagnosis, and treatment for ME/CFS and Long COVID.
Please enjoy these photos from the OMF team in Cambridge:
Special thanks to all who attended this year:
- Wenzhong Xiao, PhD, Computational Research Center for Complex Diseases
- Jonas Bergquist, MD, PhD, Collaborative Center at Uppsala
- Maureen Hansen, PhD
- Linda Tannenbaum, Founder and CEO
- Kimberly Hicks, COO and CFO
- Danielle Meadows, PhD, VP of Research Programs and Operations
- Janet Dafoe, PhD
- Ron Davis, PhD, Collaborative Center at Stanford University
- Christopher Armstrong, PhD, Melbourne ME/CFS Collaboration
- Alain Moreau, PhD, Collaborative Center at Montreal
At OMF, we’re committed to an internationally-based research network instead of single researchers to ensure the stability and collaboration essential for an outcomes-focused, transparent, and multi-pronged approach to finding answers.
Donate your appreciated stock directly to OMF and you can receive an immediate income-tax deduction for the fair market value of the securities on the date of transfer (even if you originally paid much less for them).